There pathway to increase T is not as straightforward as LPCN's. Think FDA will have a problem with that.
Does hofno2003 agree with you?
Do more DD. Liver not involved
Don't think the market gave us the proper response from the good news of trial change so we go up
Because of Chippy going to spend GERN money to buy some trash biotech
Desh is a con man nothing more....
Yes....cash burn would be reduced
But the company's market cap is still way undervalued for it's potential....Even if it doubled from here it would not be overvalued....
Yes! I agree...you nailed it!
Just can't seem to say goodby to this pig
Curious mike...can you give your opinion of NVIV doing an ATM instead of a traditional secondary?
Just got to let it happen....
Good to hear from you again...